Status:
UNKNOWN
ADAMTS,Proteoglycan and Oxidant / Antioxidant Enzyme Levels of Placenta Previa Totalis (Accreta, Increta, Percreta).
Lead Sponsor:
Zekai Tahir Burak Women's Health Research and Education Hospital
Conditions:
Placenta Previa
Eligibility:
FEMALE
25-40 years
Brief Summary
Placenta previa totalis (accreta, increta, percreta); ADAMTS and proteoglycans and the oxidant / antioxidant enzyme levels.
Detailed Description
Placenta previa totalis (accreta, increta, percreta) of pregnant women in the maternal serum, fetal membranes (placenta) and hysterectomy of women with myometrial strips measured the ADAMTS and proteo...
Eligibility Criteria
Inclusion
- pregnant women diagnosed with placenta previa by obstetric ultrasound and doppler
Exclusion
- Pregnant women with comorbid diseases other than previa totalis .
Key Trial Info
Start Date :
August 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2015
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT02270593
Start Date
August 1 2013
End Date
October 1 2015
Last Update
October 21 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zekai Tahir Burak Women's Health Education and Research Hospital
Ankara, Turkey (Türkiye)